Let’s take the next step in AHP research, together

The ENVISION clinical trial is evaluating investigational medication for acute hepatic porphyrias (AHPs), also known as acute porphyrias which include:

  • Acute intermittent porphyria (AIP)
  • Hereditary coproporphyria (HCP)
  • Variegate porphyria (VP)
  • ALAD-deficient porphyria (ADP)

The purpose of this clinical trial is to find out whether an investigational medication, givosiran, can prevent or reduce attacks and symptoms associated with porphyria. It is also looking to better understand the safety of givosiran and how the how the body responds to it.

Consider participating in the ENVISION trial.

see if you may be eligible

Refer a friend